{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "8bdce99a",
   "metadata": {},
   "source": [
    "***Extractive step: BioBERT, K means***"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2a512c38",
   "metadata": {},
   "source": [
    "pipeline:\n",
    "I use BioBERT for embdeddings\n",
    "\n",
    "I use Spacy for sentence segmentation \n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "!pip install -q spacy\n",
    "!python -m spacy download en_core_web_sm"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "from google.colab import drive\n",
    "drive.mount('/content/drive')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "3774937e",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Using MPS (Metal Performance Shaders) device.\n",
      "0.0\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Users/michaelenghoekhor/Downloads/pytorch-test/env/lib/python3.8/site-packages/datasets/table.py:1421: FutureWarning: promote has been superseded by mode='default'.\n",
      "  table = cls._concat_blocks(blocks, axis=0)\n"
     ]
    }
   ],
   "source": [
    "import typing\n",
    "from pprint import pprint\n",
    "import os\n",
    "import pickle\n",
    "import gc\n",
    "\n",
    "from transformers import BertTokenizer, BertModel\n",
    "import torch\n",
    "import numpy as np\n",
    "from sklearn.cluster import KMeans\n",
    "from datasets import load_dataset\n",
    "import pandas as pd\n",
    "from tqdm import tqdm\n",
    "\n",
    "import spacy\n",
    "# Load the SpaCy model\n",
    "nlp = spacy.load(\"en_core_web_sm\")\n",
    "\n",
    "\n",
    "# Check if MPS is available and set the device accordingly\n",
    "if torch.backends.mps.is_available():\n",
    "    device = torch.device(\"mps\")\n",
    "    print(\"Using MPS (Metal Performance Shaders) device.\")\n",
    "    os.environ['PYTORCH_MPS_HIGH_WATERMARK_RATIO'] = \"0.0\"\n",
    "    print(os.getenv('PYTORCH_MPS_HIGH_WATERMARK_RATIO'))\n",
    "elif torch.cuda.is_available():\n",
    "    device = torch.device(\"cuda\")\n",
    "    print('There is CUDA GPU available!')\n",
    "    max_split_size_mb = 256  # Set the max_split_size_mb value (e.g., 512 MB)\n",
    "    os.environ[\"PYTORCH_CUDA_ALLOC_CONF\"] = f\"max_split_size_mb:{max_split_size_mb}\"\n",
    "    print(f\"PYTORCH_CUDA_ALLOC_CONF is set to: {os.environ['PYTORCH_CUDA_ALLOC_CONF']}\")\n",
    "    os.environ['CUDA_LAUNCH_BLOCKING'] = \"1\"\n",
    "else:\n",
    "    device = torch.device(\"cpu\")\n",
    "    print(\"MPS not available. Using CPU.\")\n",
    "\n",
    "# Load the dataset and cut down\n",
    "dataset = load_dataset(\"allenai/mslr2022\", \"ms2\", split='train')\n",
    "# Use select to create a subset\n",
    "# dataset = dataset.select(range(20,21))\n",
    "\n",
    "# Initialize the BioBERT tokenizer and model\n",
    "tokenizer = BertTokenizer.from_pretrained('dmis-lab/biobert-base-cased-v1.1')\n",
    "model = typing.cast(BertModel, BertModel.from_pretrained('dmis-lab/biobert-base-cased-v1.1').to(device))\n",
    "\n",
    "csv_file_path = 'biobert_extractive_only_training_dataset.csv'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "def bert_sentence_embeddings(sentences: typing.List[str]):\n",
    "    # Move inputs to the device\n",
    "    inputs = tokenizer(sentences, return_tensors='pt', padding=True, truncation=True, max_length=512).to(device)\n",
    "    with torch.no_grad():\n",
    "        outputs = model(**inputs)\n",
    "    # Move outputs back to CPU and compute mean\n",
    "    embeddings = outputs.last_hidden_state.mean(dim=1).squeeze().cpu().numpy()\n",
    "    # clear GPU memory\n",
    "    del inputs, outputs\n",
    "    # torch.mps.empty_cache()\n",
    "    torch.cuda.empty_cache()\n",
    "    gc.collect()\n",
    "\n",
    "    return embeddings\n",
    "\n",
    "\n",
    "def select_top_sentences(sentences, embeddings, n_sentences=5):\n",
    "    # this is fixed : each selected sentence is from a different cluster\n",
    "    if len(sentences) <= n_sentences:\n",
    "        return ' '.join(sentences)\n",
    "\n",
    "    kmeans = KMeans(n_clusters=n_sentences, n_init=10)\n",
    "    kmeans.fit(embeddings)\n",
    "\n",
    "    # Initialize a set to store indices of selected sentences\n",
    "    selected_indices = set()\n",
    "    top_sentences = []\n",
    "    top_sentences_indices = []\n",
    "\n",
    "    for i in range(n_sentences):\n",
    "        # Calculate distances of all sentences from the i-th centroid\n",
    "        distances = np.linalg.norm(embeddings - kmeans.cluster_centers_[i], axis=1)\n",
    "\n",
    "        # Sort the sentences by their distance from the centroid\n",
    "        sorted_indices = np.argsort(distances)\n",
    "\n",
    "        # Find the closest sentence that hasn't been selected yet\n",
    "        for index in sorted_indices:\n",
    "            if index not in selected_indices:\n",
    "                selected_indices.add(index)\n",
    "                top_sentences.append(sentences[index])\n",
    "                top_sentences_indices.append(index)\n",
    "                break\n",
    "\n",
    "    return ' '.join([sentences[i] + (\"\" if sentences[i].endswith(\".\") else \".\") for i in sorted(top_sentences_indices)])\n",
    "\n",
    "\n",
    "save_path = \"biobert_extractive_only_training_dataset\"\n",
    "# save_path = \"/content/drive/MyDrive/266: NLP/266 final project/extractive_abstractive/biobert_kmeans_training_mk/extractive_output\"  # for Colab\n",
    "# save_path = \"/content/drive/MyDrive/266 final project/extractive_abstractive/biobert_kmeans_training_mk/extractive_output\"  # for Colab\n",
    "\n",
    "\n",
    "def process_row(row):\n",
    "    review_id = row['review_id']\n",
    "    abstract_list = row['abstract']\n",
    "\n",
    "    # check if saved\n",
    "    if os.path.exists(f'{save_path}/{review_id}.pkl'):\n",
    "        with open(f'{save_path}/{review_id}.pkl', 'rb') as file:\n",
    "            ret = pickle.load(file)\n",
    "\n",
    "    else:\n",
    "        combined_summary = ''\n",
    "\n",
    "        all_sentences = []\n",
    "        all_embeddings = []\n",
    "\n",
    "        for abstract in abstract_list:\n",
    "            # Check if the abstract is a string; if not, join it into a single string\n",
    "            abstract_text = ' '.join(abstract) if isinstance(abstract, list) else abstract\n",
    "\n",
    "            # Use SpaCy for sentence segmentation\n",
    "            doc = nlp(abstract_text)\n",
    "            sentences = [sent.text.strip() for sent in doc.sents]\n",
    "            all_sentences.append(sentences)\n",
    "\n",
    "            # Generate embeddings for each sentence\n",
    "            embeddings = bert_sentence_embeddings(sentences)\n",
    "            all_embeddings.extend(embeddings)\n",
    "            # Select the top sentences from these embeddings\n",
    "            summary = select_top_sentences(sentences, embeddings)\n",
    "\n",
    "            # Combine the summaries from each abstract\n",
    "            combined_summary += summary + (' ' if summary.endswith(\".\") else \". \")\n",
    "\n",
    "        # intermediate save\n",
    "        with open(f'{save_path}/{review_id}.pkl', 'wb') as file:\n",
    "            ret = {\n",
    "                \"review_id\": review_id,\n",
    "                \"summary\": combined_summary.strip(),\n",
    "                \"sentences\": all_sentences,  # save all to disk\n",
    "                \"embeddings\": all_embeddings,\n",
    "            }\n",
    "            pickle.dump(ret, file)\n",
    "\n",
    "    # get rid of sentences and embeddings\n",
    "    del ret['sentences']\n",
    "    del ret['embeddings']\n",
    "    return ret\n",
    "\n",
    "\n",
    "# Apply the function to each element of the dataset\n",
    "summaries_dataset = dataset.map(process_row, num_proc=1)  # CHANGE THIS APPROPRIATELY\n",
    "\n",
    "# Saving the dataset\n",
    "with open(f'{save_path}/biobert_extractive_only_training_dataset.pkl', 'wb') as file:\n",
    "    pickle.dump(summaries_dataset, file)\n",
    "\n",
    "\n",
    "# Convert to pandas DataFrame\n",
    "df = pd.DataFrame(summaries_dataset)\n",
    "df = df[['review_id', 'summary']]\n",
    "\n",
    "# Save to CSV\n",
    "df.to_csv(csv_file_path, index=True)\n",
    "\n",
    "print(f\"Saved summaries to {csv_file_path}\")\n",
    "\n",
    "# disconnect Google Colab\n",
    "from google.colab import runtime\n",
    "runtime.unassign()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Dataset({\n",
       "    features: ['review_id', 'pmid', 'title', 'abstract', 'target', 'background'],\n",
       "    num_rows: 14188\n",
       "})"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Reminder of what training dataset looks like\n",
    "dataset"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Unzipping extractive_output-20231202T030259Z-004.zip\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 2389/2389 [00:20<00:00, 117.97it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Unzipping extractive_output-20231202T030259Z-005.zip\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 2146/2146 [00:18<00:00, 114.50it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Unzipping extractive_output-20231202T030259Z-006.zip\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 1635/1635 [00:14<00:00, 116.76it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Unzipping extractive_output-20231202T030259Z-002.zip\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 2566/2566 [00:21<00:00, 119.52it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Unzipping extractive_output-20231202T030259Z-003.zip\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 2464/2464 [00:20<00:00, 118.55it/s]\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Unzipping extractive_output-20231202T030259Z-001.zip\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████| 3002/3002 [00:24<00:00, 120.70it/s]\n"
     ]
    }
   ],
   "source": [
    "# The above was run across multiple devices. Combined results are available in experiment_1/biobert_extractive_only_training_dataset_zipped in separate zipped files.\n",
    "# 1. Initiate an empty dict\n",
    "# 2. For each zipped file:\n",
    "# 2.1. Unzip a zipped file\n",
    "# 2.2. Iterate through the unzipped files (pkl files):\n",
    "# 2.2.1. Verify that the file belongs to `dataset`\n",
    "# 2.2.2. Retrieve the review_id and summary\n",
    "# 2.2.3. Update dict with review_id as key and summary as value\n",
    "# 2.3. Delete the unzipped files\n",
    "# 2.4. Intermittently save the dict to disk\n",
    "# 3. Convert the dict to a pandas DataFrame, save it.\n",
    "\n",
    "RELATIVE_PATH_TO_ZIPPED_FILES = \"biobert_extractive_only_training_dataset_zipped\"\n",
    "\n",
    "# 1. Initiate an empty dict\n",
    "combined_dict = {}\n",
    "bad_files = []\n",
    "\n",
    "# 2. For each zipped file:\n",
    "for i, zipfile in enumerate(os.listdir(RELATIVE_PATH_TO_ZIPPED_FILES)):\n",
    "    # 2.1. Unzip a zipped file\n",
    "    print(f\"Unzipping {zipfile}\")\n",
    "    !unzip -q \"{RELATIVE_PATH_TO_ZIPPED_FILES}/{zipfile}\" -d \"biobert_extractive_only_training_dataset_zipped_{i}\"\n",
    "    # 2.2. Iterate through the unzipped files (pkl files):\n",
    "    for file in tqdm(os.listdir(f\"biobert_extractive_only_training_dataset_zipped_{i}/extractive_output\")):\n",
    "        if file.endswith(\".pkl\"):\n",
    "            # 2.2.1. Verify that the file belongs to `dataset`\n",
    "            review_id = file.split('.')[0]\n",
    "            if not review_id in dataset[\"review_id\"]:\n",
    "                bad_files.append(file)\n",
    "                continue\n",
    "\n",
    "            # 2.2.2. Retrieve the review_id and summary\n",
    "            with open(f\"biobert_extractive_only_training_dataset_zipped_{i}/extractive_output/{file}\", 'rb') as f:\n",
    "                file_contents = pickle.load(f)\n",
    "                review_id = file_contents['review_id']\n",
    "                summary = file_contents['summary']\n",
    "                # 2.2.3. Update dict with review_id as key and summary as value\n",
    "                combined_dict[review_id] = summary\n",
    "\n",
    "    # 2.3. Delete the unzipped files\n",
    "    !rm -rf biobert_extractive_only_training_dataset_zipped_{i}\n",
    "    # 2.4. Intermittently save the dict to disk\n",
    "    with open(\"biobert_extractive_only_training_dataset.pkl\", 'wb') as f:\n",
    "        pickle.dump(combined_dict, f)\n",
    "\n",
    "    gc.collect()\n",
    "\n",
    "\n",
    "# 3. Convert the dict to a pandas DataFrame, save it.\n",
    "df = pd.DataFrame.from_dict(combined_dict, orient='index', columns=['summary'])\n",
    "df.index.name = 'review_id'\n",
    "# save compressed\n",
    "df.to_csv(\"biobert_extractive_only_training_dataset.csv.gz\", compression='gzip')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [],
   "source": [
    "df.to_csv(\"biobert_extractive_only_training_dataset.csv.gz\", compression='gzip')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [],
   "source": [
    "# to open gzip pandas csv file\n",
    "df = pd.read_csv(\"biobert_extractive_only_training_dataset.csv.gz\", compression='gzip', index_col=0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(14188, 1)"
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>summary</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>review_id</th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>19277023</th>\n",
       "      <td>METHODS Forty-eight patients with Rome II IBS ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25108741</th>\n",
       "      <td>Therefore , improved approaches to smoking ces...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23052919</th>\n",
       "      <td>Summary : We initiated a r and omized study of...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25019658</th>\n",
       "      <td>DESIGN R and omized controlled trial . INTERVE...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26677846</th>\n",
       "      <td>We investigated the combination of pertuzumab ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                     summary\n",
       "review_id                                                   \n",
       "19277023   METHODS Forty-eight patients with Rome II IBS ...\n",
       "25108741   Therefore , improved approaches to smoking ces...\n",
       "23052919   Summary : We initiated a r and omized study of...\n",
       "25019658   DESIGN R and omized controlled trial . INTERVE...\n",
       "26677846   We investigated the combination of pertuzumab ..."
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# count how many files are in the directory\n",
    "import os\n",
    "from tqdm import tqdm\n",
    "print(\"total generated:\", len(os.listdir(save_path)))\n",
    "print(\"total expected:\", len(dataset))\n",
    "\n",
    "# if there are any missing from `dataset`, list them. infer from file name\n",
    "missing = []\n",
    "for review_id in tqdm(dataset['review_id']):\n",
    "    if not os.path.exists(f'{save_path}/{review_id}.pkl'):\n",
    "        missing.append(review_id)\n",
    "\n",
    "print(len(missing))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 95,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[['The influence of diurnal variations of mood ( DVM ) and sleep disturbances on treatment response was investigated in 42 patients with major depressive disorder ( not SAD ) under the treatment of '\n",
      "  'either bright white light ( 2,500 lx ) or dim red light ( 50 lx ) .',\n",
      "  'We found only a slight influence in certain subscales of DVM and no influence of sleep disturbances .',\n",
      "  'These results are discussed under a clinical point of view and with respect to phase shift theories of depressive disorders'],\n",
      " ['In a group of 17 patients with non-SAD depressive disorders we compared the response of bipolar spectrum versus unipolar patients to treatment with light therapy .',\n",
      "  'The main hypothesis was that bipolar spectrum depressed patients would preferentially respond to bright light therapy as compared to unipolar depressed patients .',\n",
      "  'All patients were treated with either 400 or 2500 lux phototherapy for 2 h on seven consecutive days .',\n",
      "  'All outcome measures , which included the SIGH-SAD , CGI , and the Anxiety and Depressive Factors of the SCL-90 , showed significant improvement in the bipolar vs. the unipolar spectrum patients '\n",
      "  '.',\n",
      "  'Unexpected this occurred regardless of the intensity of the light .',\n",
      "  'These changes were judged to be quite clinical ly significant .',\n",
      "  'All patients showing response were noted to have maintained their response at a 3-month follow-up'],\n",
      " ['Patients with recurrent winter depression and its subsyndromal form have been reported to benefit from bright full-spectrum light ( phototherapy ) .',\n",
      "  'In order to determine whether this treatment ( 2 h in the morning ) during winter is effective in a r and om sample of the general population we investigated the responses of 20 subjects with '\n",
      "  'varying degrees of winter difficulties .',\n",
      "  'A control group ( n = 20 ) matched for the degree of seasonality , age , and sex was treated with dim light .',\n",
      "  'Individuals were selected from a larger survey sample of the Montgomery County population ( MD , U.S.A. ) and were comparable to the latter in their degree of winter difficulties .',\n",
      "  'Enhancement of environmental light does not , on the basis of the present study , appear to be indicated for the public at large , but rather for a subgroup of individuals with histories of '\n",
      "  'winter difficulties'],\n",
      " ['Light  therapy ( LT ) is regarded as the treatment of choice for seasonal affective disorder ( SAD ) .',\n",
      "  'In nonseasonal depression the results of light therapy are nonconclusive .',\n",
      "  'Sleep deprivation ( SD )  , however , is effective in 50 - 60 % of the patients with major depression .',\n",
      "  'The predictive value of  Total Sleep Deprivation ( TSD ) for the treatment outcome of antidepressiva has been already examined .',\n",
      "  'Purpose of the present study was to test whether  light therapy  is more beneficial in TSD responders than in TSD nonresponders .',\n",
      "  '40 in patients with major depressive disorder completed one night of TSD .',\n",
      "  'Twenty TSD responders and 20 TSD nonresponders were r and omly assigned to 14 days of bright light therapy ( 2500 lux , 7 - 9 a.m. ) or 14 days of dim light therapy ( red light 50 lux , 7 - 9 '\n",
      "  'a.m. ) .',\n",
      "  'Manova with repeated measurements revealed a significant difference in the course of depression over the time between TSD responders and nonresponders , but no significant difference between '\n",
      "  'bright and dim light .',\n",
      "  'Questions of  placebo effect , of SAD and of personality variables as predictors of response to  SD and LT  are being discussed'],\n",
      " ['Phototherapy is regularly used in the treatment of  seasonal affective disorder .',\n",
      "  'There is evidence that it is also useful in the treatment of  non‐seasonal depression  , but relevant controlled experiments are difficult to design .',\n",
      "  'In this study we r and omly assigned depressed in‐ patients to high and low levels of artificial light , the high levels exceeding those most commonly used in earlier reported trials .',\n",
      "  'Both unipolar and bipolar depressions responded when phototherapy was used as an adjunct to pharmacotherapy , and mood improvement was related to the intensity of illumination , that is , '\n",
      "  'patients treated with high levels of illumination improved significantly more than those who received low levels ( P < 0.02 ) .',\n",
      "  'Our findings suggest that light therapy is generally applicable to depressive illnesses , and that the light intensities commonly used are suboptimal'],\n",
      " ['The data of the Berlin light therapy study were systematic ally reinvestigated for side-effects of light therapy as described in the literature .',\n",
      "  'Forty-two patients with major depressive disorder ( RDC ) , who also met the criteria of ICD-9 ( 296.1 and 296.3 ) , were included .',\n",
      "  'Patients were either given bright white-light treatment ( 2,500 lux ) or dim red-light treatment ( 50 lux ) from 7.20 a.m. to 9.20 a.m. every morning for a period of seven days .',\n",
      "  'The study did not reveal any differences in side-effects between the two treatments .',\n",
      "  'The results are discussed in relation to the two different treatment conditions'],\n",
      " ['The effects of two non-drug treatments ( physical exercise and bright light ) on mood , body weight and oxygen consumption were compared in age-matched groups of female subjects with winter '\n",
      "  'depression , non-seasonal depression or without depression .',\n",
      "  'It was found that oxygen consumption in the pre-treatment condition was similar in non-depressed subjects ( n=18 ) and depressed non-seasonals ( n=18 ) , while comparatively lower values were '\n",
      "  'obtained in winter depression ( n=27 ) .',\n",
      "  'Neither mood nor metabolic parameters changed significantly in the group of nine untreated winter depressives .',\n",
      "  'One week of physical exercise ( 1-h pedaling on a bicycle ergometer between 13.00 and 14.00 h ) increased oxygen consumption in the group of nine winter depressives and lowered oxygen consumption '\n",
      "  'in nine-subject groups of depressed and non-depressed non-seasonals .',\n",
      "  'One week of bright light treatment ( 2-h exposure to 2500 lux between 14.00 and 16.00 h ) increased oxygen consumption in nine winter depressives and nine non-depressed subjects , while no '\n",
      "  'significant change in oxygen consumption was found in nine subjects with non-seasonal depression .',\n",
      "  'Weight loss was observed in the groups treated with physical exercise and in the group of light-treated winter depressives .',\n",
      "  'Winter depression responded equally well to exercising and light , while a significant therapeutic difference in favor of exercising was found in non-seasonal depression .',\n",
      "  'Overall , the results of the study suggest that energy-regulating systems are implicated in the antidepressant action of the non-drug treatments'],\n",
      " ['The clinical usefulness of total sleep deprivation ( TSD ) in the treatment of bipolar depression is hampered by a high-rate short-term relapse .',\n",
      "  'Previous literature has suggested that both long-term lithium treatment and light therapy could successfully prevent relapse .',\n",
      "  'We r and omized 115 bipolar depressed in patients to receive three cycles of TSD , alone or in combination with morning light exposure , given at an intensity of 150 or 2500 lux .',\n",
      "  'Forty-nine patients were undergoing long-term treatment with lithium salts ( at least 6 months ) , while 66 patients were taking no psychotropic medication .',\n",
      "  'Mood was self-rated by the Visual Analogue Scale three times a day during treatment .',\n",
      "  'The results showed that both light therapy and ongoing lithium treatment significantly enhanced the effects of TSD on the perceived mood , with no additional benefit when the two treatments were '\n",
      "  'combined .',\n",
      "  'Subjective sleepiness during TSD , as rated by the self-administered Stanford Sleepiness Scale , was significantly reduced by light exposure , and was correlated with the outcome .',\n",
      "  'This study confirms the possibility of obtaining a sustained antidepressant response to TSD in bipolar patients'],\n",
      " ['In previous research , the therapeutic effect of bright white light for so so-called seasonal affective disorder was clearly confirmed .',\n",
      "  'The aim of the present study was to evaluate possible beneficial effects of bright white light in non-seasonal depression .',\n",
      "  '30 patients fulfilling RDC- criteria for major depressive disorder were r and omly assigned to a 7 day exposure from 7.20 to 9.20 a.m.',\n",
      "  'The degree of illness was ascertained both objective ly with observer rating scales ( Hamilton Depression Scale , AMDP-system ) and through self-rating scales ( Complaint List and Depression '\n",
      "  'Scale by von Zerssen ) .',\n",
      "  'No difference was noted between bright light and dim light though a significant reduction of depressive symptomatology was observed for all patients during the treatment .',\n",
      "  'These results were consistent for both observer rating and self-rating .',\n",
      "  'In conclusion , bright white light has no superior effect as compared to dim light exposure in non-seasonal depression'],\n",
      " ['INTRODUCTION The aim of a double-blind study was to assess the efficacy of bright light therapy and /or imipramine in the treatment of in patients suffering with recurrent non-seasonal major '\n",
      "  'depressive disorder .',\n",
      "  'METHOD 34 in- patients with DSM-III-R diagnosis of major depressive disorder , recurrent type , were r and omly allocated into 3 treatment groups .',\n",
      "  'After 4-day washout period with baseline assessment they underwent 3 weeks of different types of treatment : a ) Group A : bright light therapy ( 5000 lux from 6 - 8 a.m. ) and imipramine 150 '\n",
      "  'mg/day .',\n",
      "  'b ) Group B : bright light therapy ( 5000 lux from 6 - 8 a.m. ) and imipramine-like placebo .',\n",
      "  'c )',\n",
      "  'Group C : dim red light ( 500 lux from 6 - 8 a.m. ) and imipramine 150 mg/day .',\n",
      "  'Outcome measures included weekly Hamilton Psychiatric Rating Scale for Depression , Clinical Global Impression Scale , Montgomery and Asberg Psychiatric Rating Scale for Depression and Beck '\n",
      "  'Depression Inventory .',\n",
      "  'RESULTS Patients of all three groups improved significantly .',\n",
      "  'The improvement of the patients of group B treated with bright light therapy plus placebo was superior to the other two groups , but not significantly .',\n",
      "  'CONCLUSION Bright light therapy can be effective in the treatment of non-seasonal major depressive disorder'],\n",
      " ['Light therapy ( bright or dim light ) was given at different times ( morning or evening ) to 27 unmedicated patients with nonseasonal depression ( according to DSM-III-R criteria ) and 16 normal '\n",
      "  'volunteers .',\n",
      "  'Circadian rhythms in body temperature were measured before and after light therapy .',\n",
      "  'Bright light significantly improved clinical symptoms of depression , as measured by the Hamilton Rating Scale for Depression ( HRSD ) , independent of the time of phototherapy .',\n",
      "  'Dim light therapy had no effect on HRSD scores .',\n",
      "  'Circadian rhythms of body temperatures in patients with affective disorder were more sensitive to the entraining effects of bright light than those of normal subjects , but these effects were not '\n",
      "  'related to clinical improvement .',\n",
      "  'Bright light exposure has an antidepressant effect on patients with nonseasonal depression , but the effect is unlikely to be mediated via the same circadian system that regulates body '\n",
      "  'temperature'],\n",
      " ['OBJECTIVE About 5 % of pregnant women meet criteria for major depression .',\n",
      "  'No pharmacotherapy is specifically approved for antepartum depression ; novel treatment approaches may be welcome .',\n",
      "  'The authors explored the use of morning bright light therapy for antepartum depression .',\n",
      "  'METHOD An open trial of bright light therapy in an A-B-A design was conducted for 3 - 5 weeks in 16 pregnant patients with major depression .',\n",
      "  'The Hamilton Depression Rating Scale , Seasonal Affective Disorders Version , was administered to assess changes in mood .',\n",
      "  'A follow-up question naire was used to assess outcome after delivery .',\n",
      "  'RESULTS',\n",
      "  'After 3 weeks of treatment , mean depression ratings improved by 49 % .',\n",
      "  'Benefits were seen through 5 weeks of treatment .',\n",
      "  'There was no evidence of adverse effects of light therapy on pregnancy .',\n",
      "  'CONCLUSIONS These data provide evidence that morning light therapy has an antidepressant effect during pregnancy .',\n",
      "  'A r and omized controlled trial is warranted to test this alternative to medication'],\n",
      " ['Inpatient studies have suggested that bright light therapy can be used to sustain the antidepressant effects of wake therapy ( sleep deprivation ) .',\n",
      "  'In an outpatient trial , a half night of home wake treatment was followed by 1 week of light treatment .',\n",
      "  'All subjects had Major Depressive Disorders according to DSM-IV criteria and were receiving concomitant antidepressant medication .',\n",
      "  'Subjects were r and omly assigned to receive either 10,000 lux bright white light for 30 min between 6 and 9 AM or dim red ( placebo ) light at a comparable time .',\n",
      "  'Seven subjects completed treatment with bright white light and six completed treatment with placebo .',\n",
      "  'On the Hamilton Depression Rating Scale ( HDRS17 , SIGH-SAD-SR version ) , the group receiving bright light improved 27 % in 1 week ( P=0.002 ) .',\n",
      "  'The group receiving placebo did not improve , except for one outlier .',\n",
      "  'The benefit of bright light was significant compared to placebo with removal of the outlier ( P<0.025 )'],\n",
      " ['Antidepressant and energizing effects of bright light exposure ( phototherapy ) have been widely reported to occur in patients with seasonal affective disorder .',\n",
      "  'We have attempted to evaluate whether other segments of the population might benefit from phototherapy , most notably individuals with subsyndromal seasonal affective disorder , as well as '\n",
      "  'healthy individuals with no winter difficulties ( controls ) .',\n",
      "  'We have studied 20 subjects in each of these two categories and have found that bright artificial light did not alter mood and behavior in controls .',\n",
      "  'In contrast , individuals with subsyndromal seasonal affective disorder responded favorably to treatment with bright environmental light .',\n",
      "  'A dose of 5 hours of bright light exposure , divided between morning and evening , was more effective than 2 hours of exposure .',\n",
      "  'This finding may have practical implication s for establishing optimal environmental lighting conditions for those individuals whose winter difficulties do not meet criteria for seasonal '\n",
      "  'affective disorder'],\n",
      " ['BACKGROUND Using bright light for treating major depressive disorders which are not seasonal needs re assessment .',\n",
      "  'METHODS Clinical trials of light treatment for nonseasonal major depressive disorders were compared with selected trials of light treatment of winter depression and with antidepressant clinical '\n",
      "  'drug trials .',\n",
      "  'RESULTS Light treatment of nonseasonal depression produces net benefits in the range of 12 - 35 % , often within 1 week .',\n",
      "  \"CONCLUSIONS Light 's value for nonseasonal and seasonal depression are comparable .\",\n",
      "  'Light appears to produce faster antidepressant benefits than psychopharmacologic treatment .',\n",
      "  'LIMITATIONS Direct r and omizing comparisons between light and medications for nonseasonal depression are not available .',\n",
      "  'CLINICAL RELEVANCE',\n",
      "  'Bright light can be combined with st and ard therapies for treating nonseasonal depressions and appears synergistic'],\n",
      " ['Serum concentrations of thyroxine ( T4 ) , triiodothyronine ( T3 ) , and thyrotropine were measured in 34 patients with nonseasonal affective disorders before and after 1 week of light treatment '\n",
      "  '.',\n",
      "  'Nineteen of these patients received bright white light ( 2500 lx ) and 15 dim red light ( 50 lx ) for 2 hours daily in the mornings over a 1-week period .',\n",
      "  'Slight but significant reductions in the rating scores for the depressive symptomatology were found for both the bright- and dim-light groups , but there were no significant differences between '\n",
      "  'the two groups .',\n",
      "  'The improvement is thus most likely a placebo effect .',\n",
      "  'Surprisingly , the small changes in the severity of the depressive symptoms in the group as a whole were significantly correlated to the changes in the serum levels of T4 during the weeks of '\n",
      "  'bright- and dim-light treatment , respectively .',\n",
      "  'The more a patient improved , the further his or her T4 level fell and vice versa .',\n",
      "  'The fluctuations in the concentrations of T4 during light treatment  were significantly greater in the depressed patients than in a group of 12 healthy controls who also received bright or dim '\n",
      "  'light , whereas the changes in T3 were significantly smaller than those of the healthy controls .',\n",
      "  'The pronounced fluctuations in T4 levels were probably not secondary to changes in mood .',\n",
      "  'Rather , they are likely to reflect changes in tissue ( intracellular ) metabolism of T4 , which may be involved in the mechanisms underlying the fluctuations in mood in these patients'],\n",
      " ['The present study was design ed to investigate the clinical efficacy of trimipramine with adjunct sleep deprivation ( SD ) or bright light ( BL )  and to evaluate psychometric and neurobiological '\n",
      "  'variables that might be of predictive value for treatment response .',\n",
      "  'We used ( 1 ) the combined dexamethasone-corticotropin releasing hormone test ( DEX-CRH test ) to characterize alterations of the hypothalamic-pituitary-adrenal ( HPA ) system ; ( 2 ) '\n",
      "  'polysomnography to evaluate sleep disturbances ; and ( 3 ) a st and ardized test battery to assess cognitive psychomotor functions after study initiation and after 5 weeks of treatment .',\n",
      "  'The overall response rate ( > or = 50 % decrease in score on Hamilton Rating Scale for Depression [ HRS ] ) was 55 % ( N = 42 ) .',\n",
      "  'The response rate in the group with trimipramine monotherapy ( N = 14 ) was 79 % , whereas in the groups with adjunct SD ( N = 14 ) and BL ( N = 14 ) , respectively , it was only 43 % .',\n",
      "  'All three groups showed significant improvement at the end of the third week of treatment .',\n",
      "  'Neither of the adjunct treatments hastened the onset of antidepressant action as measured by HRS .',\n",
      "  'A significantly higher proportion of nonresponders than responders ( p < .05 ) had HPA dysregulation , disturbed rapid eye movement ( REM ) sleep ( REM latency , REM% first third of night ) and '\n",
      "  'decreased non-REM sleep ( % stage 2 ) .',\n",
      "  'The non-responders showed significantly more corticotropin ( ACTH ) secretion after CRH stimulation in the DEX-CRH test than the responders and a less rapid normalization of the neuroendocrine '\n",
      "  'dysregulation ( cortisol secretion ) ( p < .01 ) .',\n",
      "  'In addition , REM latency was significantly shorter in the BL group than in the monotherapy group and estimated duration of illness significantly longer in the SD group than in the monotherapy '\n",
      "  'group .',\n",
      "  'REM latency , percentage of REM sleep during the first third of the total sleep period , percentage of non-REM sleep stage 2 and ACTH release after a DEX-CRH challenge predicted response across '\n",
      "  'all three treatment groups .',\n",
      "  'The neurobiological symptoms were unevenly distributed , among the three groups , thus creating heterogeneity in these measures .',\n",
      "  'This heterogeneity may have contributed to the different treatment response rates as defined by psychopathology ( HRS ) .',\n",
      "  'In contrast , the neuropsychological tests and some of the sleep-EEG investigations revealed different response patterns for different groups : The onset of improvement in simple cognitive '\n",
      "  'functions and in sleep continuity was earlier in the adjunct treatment groups .',\n",
      "  'This study underlines the need for a multidimensional approach including use of neurobiological and neuropsychological measures to identify the therapeutic profiles of different treatment '\n",
      "  'strategies and predictors of outcome'],\n",
      " [\"ABSTRACT The purpose of this study was to test the efficacy of a tri-modal intervention ( LEVITY ) to improve  women 's mood .\",\n",
      "  'This eight-week r and omized experiment with a placebo-control group targeted women with symptoms of mild to moderate depression .',\n",
      "  'Women in the intervention group were instructed to take a brisk 20-minute outdoor walk at target heart rate of 60 % of maximum heart rate , to increase light exposure throughout the day and to '\n",
      "  'take a specific vitamin regimen .',\n",
      "  'Women in the control group took a daily placebo vitamin .',\n",
      "  'The sample consisted of 112 women ages 19–78 who reported mild to moderate depressive symptoms .',\n",
      "  'They were in otherwise good health and were not currently taking any mood-altering medication .',\n",
      "  'Pre- and post-intervention assessment utilized five measures of mood : Center for Epidemiology Studies Depression Scale , Profile of Mood States , Depression-Happiness Scale , Rosenberg '\n",
      "  'Self-Esteem Scale , and the General Well-Being Schedule .',\n",
      "  \"Analysis of covariance indicated that the intervention was effective in improving women 's overall mood , self-esteem , and general sense of well-being and in decreasing symptoms on two measures \"\n",
      "  'of depression .',\n",
      "  'Of particular note , the data from all five outcome measures supported the efficacy of the intervention .',\n",
      "  'In addition , a high level of adherence to the intervention protocol was observed with two-thirds of the women reporting 100 % adherence .',\n",
      "  'Study implication s suggest that this type of intervention may provide an effective , clinical ly manageable therapy for mild-to-moderately depressed women who prefer a self-directed approach or '\n",
      "  'who have difficulties with the cost or side-effects of medication or psychotherapy'],\n",
      " ['We investigated the effectiveness of two brief psychotherapies , interpersonal psychotherapy and cognitive behavior therapy , for the treatment of out patients with major depression disorder '\n",
      "  'diagnosed by Research Diagnostic Criteria .',\n",
      "  'Two hundred fifty patients were r and omly assigned to one of four 16-week treatment conditions : interpersonal psychotherapy , cognitive behavior therapy , imipramine hydrochloride plus clinical '\n",
      "  'management ( as a st and ard reference treatment ) , and placebo plus clinical management .',\n",
      "  'Patients in all treatments showed significant reduction in depressive symptoms and improvement in functioning over the course of treatment .',\n",
      "  'There was a consistent ordering of treatments at termination , with imipramine plus clinical management generally doing best , placebo plus clinical management worst , and the two psychotherapies '\n",
      "  'in between but generally closer to imipramine plus clinical management .',\n",
      "  'In analyses carried out on the total sample s without regard to initial severity of illness ( the primary analyses ) , there was no evidence of greater effectiveness of one of the psychotherapies '\n",
      "  'as compared with the other and no evidence that either of the psychotherapies was significantly less effective than the st and ard reference treatment , imipramine plus clinical management .',\n",
      "  'Comparing each of the psychotherapies with the placebo plus clinical management condition , there was limited evidence of the specific effectiveness of interpersonal psychotherapy and none for '\n",
      "  'cognitive behavior therapy .',\n",
      "  'Superior recovery rates were found for both interpersonal psychotherapy and imipramine plus clinical management , as compared with placebo plus clinical management .',\n",
      "  'On mean scores , however , there were few significant differences in effectiveness among the four treatments in the primary analyses .',\n",
      "  'Secondary analyses , in which patients were dichotomized on initial level of severity of depressive symptoms and impairment of functioning , helped to explain the relative lack of significant '\n",
      "  'findings in the primary analyses .',\n",
      "  'Significant differences among treatments were present only for the subgroup of patients who were more severely depressed and functionally impaired ; here , there was some evidence of the '\n",
      "  'effectiveness of interpersonal psychotherapy  with these patients and strong evidence of the effectiveness of imipramine plus clinical management .',\n",
      "  'In contrast , there were no significant differences among treatments , including placebo plus clinical management , for the less severely depressed and functionally impaired patients'],\n",
      " ['Circadian profiles of melatonin in serum and serotonin in blood were assessed before and after 7 days of artificial light treatment in 30 patients with non-seasonal depression and 12 healthy '\n",
      "  'subjects .',\n",
      "  'Patients and volunteers were allocated at r and om to either dim ( 50 lux ) or bright light ( 2,500 lux ) for 2 hours daily .',\n",
      "  'The study has not been completed yet .',\n",
      "  'Preliminary findings are presented here .',\n",
      "  'Light treatment modifies marginally the circadian melatonin profiles of depressed patients and healthy subjects ; however , it augments blood serotonin throughout the day .',\n",
      "  'This increase is seen in all patients and healthy subjects after bright as well as dim light .',\n",
      "  'These results suggest that the influence of light is more pronounced on serotonin than melatonin metabolism'],\n",
      " ['BACKGROUND An important parallel exists between patients with seasonal affective disorder and institutionalized older adults .',\n",
      "  'Many older patients , as a result of global physical decline and immobility , are confined to their rooms , experiencing little natural sunlight .',\n",
      "  'Thus , institutionalized older adults are at risk for chronic light deprivation .',\n",
      "  'Testing the hypothesis that chronic light deprivation might be responsible , at least in part , for some depression among institutionalized older adults , the aim of this study was to investigate '\n",
      "  'the efficacy of morning bright light treatment on depression among older adults residing in a long-term care facility .',\n",
      "  'METHODS',\n",
      "  'In a placebo controlled , crossover design , participants ( N = 10 , six women and four men ; M age = 83.8 ) received each of the following : ( i ) 1 week ( 5 days ) of 10,000 lux ( therapeutic '\n",
      "  'dose ) ; ( ii ) 1 week ( 5 days ) of 300 lux ( placebo ) ; or 1 week of no treatment ( control ) .',\n",
      "  'Each week of light treatment was 5 consecutive days , 30 minutes daily , with a wash-out period consisting of 1 week between conditions .',\n",
      "  'RESULTS Geriatric Depression Scale ( GDS ) scores at baseline during all treatment conditions were positively correlated ( r = .81 , p < .01 ) with months of institutionalization , where '\n",
      "  'participants with higher GDS scores experienced more time institutionalized .',\n",
      "  'Scores on the GDS remained unchanged during the placebo and control conditions , but depression scores decreased significantly during the 10,000 lux treatment ( pretest GDS M = 15 vs posttest GDS '\n",
      "  'M = 11 , p < .01 ) .',\n",
      "  'After the 10,000 lux treatment , 50 % of the participants no longer scored in the depressed range .',\n",
      "  'Improvement during the 10,000 lux condition was positively correlated ( r = .62 , p < .05 ) to baseline GDS scores , where participants with higher GDS scores experienced greater improvement '\n",
      "  'following the 10,000 lux treatment .',\n",
      "  'CONCLUSIONS The results of the present study suggest that bright light treatment may be effective among institutionalized older adults , providing nonpharmacological intervention in the treatment '\n",
      "  'of depression .',\n",
      "  'Furthermore , the length of institutionalization may play an important role in determining the efficacy of bright light treatment for older adults in the nursing-home setting'],\n",
      " ['BACKGROUND Bright artificial light improves  non-seasonal depression .',\n",
      "  'Preliminary observations suggest that sunlight could share this effect .',\n",
      "  'METHODS Length of hospitalization was recorded for a sample of 415 unipolar and 187 bipolar depressed in patients , assigned to rooms with eastern ( E ) or western ( W ) windows .',\n",
      "  'RESULTS Bipolar in patients in E rooms ( exposed to direct sunlight in the morning ) had a mean 3.67-day shorter hospital stay than patients in W rooms .',\n",
      "  'No effect was found in unipolar in patients .',\n",
      "  'CONCLUSIONS Natural sunlight can be an underestimated and uncontrolled light therapy for bipolar depression .',\n",
      "  'LIMITATIONS',\n",
      "  'This is a naturalistic retrospective observation , which needs to be confirmed by prospect i ve studies'],\n",
      " ['Nine patients with rapid cycling bipolar disorder were treated with a total of 13 trials of bright light therapy in the morning ( n = 5 ) , evening ( n = 3 ) , or midday ( n = 5 ) .',\n",
      "  \"In each instance , the patient 's mood ratings during 3 months of light therapy ( added to a stable medication regimen ) were compared to his or her mood ratings during 3 months on the same \"\n",
      "  'medication but without light treatment .',\n",
      "  'Of the 3 light therapy schedules , only midday lights appeared to have beneficial clinical effects , improving mood ratings in 3 patients .',\n",
      "  'In contrast , the morning light therapy trial was terminated prematurely in 3 patients because of clinical instability .',\n",
      "  'Light treatment was better tolerated if patients discontinued it on days when they were hypomanic .',\n",
      "  'The clinical and theoretical implication s of these preliminary findings are discussed'],\n",
      " ['Partial sleep deprivation ( PSD ) results in a pronounced decrease of depressive symptoms in the majority of patients with major depressive disorder .',\n",
      "  'Generally this acute antidepressant effect is not stable , relapse usually occurs after one night of recovery sleep .',\n",
      "  'We therefore studied whether light therapy , beginning in the morning after PSD , is able to prevent the relapse after sleep deprivation , using a controlled , balanced , parallel design .',\n",
      "  'All patients received an antidepressant medication , which was kept constant before and during the study period .',\n",
      "  'Fourteen of 20 patients ( 70 % ) showed a reduction of at least 40 % in the Hamilton Depression Rating Scale ( HDRS ) in the morning after PSD and were classified as PSD responders .',\n",
      "  'Responders as well as nonresponders were r and omly assigned to receive either bright light ( BL/3000 lux ) or dim light ( DL/100 lux ) therapy during the following 6 days after PSD .',\n",
      "  'In the responder group BL therapy prevented significantly ( p = 0.005 ) the relapse after the next night of sleep and prolonged significantly ( p = 0.011 ) the antidepressant effects of PSD up to '\n",
      "  '7 days .',\n",
      "  'In contrast , patients in the DL condition relapsed after the recovery night and showed no further improvement of the depressive syndrome after 1 week of DL therapy .',\n",
      "  'PSD nonresponders did not benefit from light treatment .',\n",
      "  'These findings indicate that BL therapy might be efficacious to prevent relapse after PSD'],\n",
      " ['BACKGROUND Selective serotonin reuptake inhibitors are effective in approximately 70 % of patients with a major depressive episode , but therapeutic changes usually require 2 weeks of '\n",
      "  'administration to become clinical ly relevant .',\n",
      "  'Adjunct light therapy has been proposed to hasten the effects of drug treatment .',\n",
      "  'The purpose of the present study was to evaluate the effect of morning light therapy or placebo combined with citalopram in the treatment of patients affected by a major depressive episode '\n",
      "  'without psychotic features .',\n",
      "  'METHOD Thirty in patients ( DSM-IV major depressive disorder [ N = 21 ] and bipolar disorder [ N = 9 ] ) were treated with citalopram , 40 mg , and r and omized in a 3:2 manner to receive 30 '\n",
      "  'minutes of 400 lux green light treatment in the morning or placebo ( exposure to a deactivated negative ion generator ) during the first 2 weeks of drug treatment .',\n",
      "  'Timing of light therapy was individually defined to obtain a 2-hour phase advance to morning light .',\n",
      "  'Outcome was measured with the Hamilton Rating Scale for Depression and the Zung Self-Rating Depression Scale every week , and with a Visual Analogue Scale 3 times a day during the first week .',\n",
      "  'RESULTS All outcome measures showed significantly ( p < .05 ) better mood improvement in light-treated patients , result ing in faster responses to antidepressant treatment .',\n",
      "  'CONCLUSION',\n",
      "  'The combination of citalopram and light treatment was more effective than citalopram and placebo in the treatment of major depression .',\n",
      "  'With an optimized timing of administration , low-intensity light treatment significantly hastened and potentiated the effect of citalopram , thus providing the clinical psychiatrists with an '\n",
      "  'augmenting strategy that was found effective and devoid of side effects'],\n",
      " ['Psychotropic drug-free hospitalized veterans with nonseasonal major depressive disorders or depressed forms of bipolar disorder were treated with light for 1 week .',\n",
      "  'Twenty-five patients were r and omly assigned to bright white light treatment ( 2000 - 3000 lux ) , and 26 patients were r and omized to dim red light placebo control treatment .',\n",
      "  'Unlike those treated with dim red light , those treated with bright white light showed declines in three measures of depression during treatment .',\n",
      "  'Partial relapse appeared within 2 days .',\n",
      "  'A global depression score showed a statistically significant ( p = 0.02 ) difference favoring bright white light treatment .',\n",
      "  'Two bright-light-treated patients became mildly hypomanic , but side effects were mild .',\n",
      "  'Improvement was not correlated with patient expectations ; indeed , patients expected somewhat greater benefit from the placebo .',\n",
      "  'Patients treated in summer responded as well as those treated in winter .',\n",
      "  'Baseline electroencephalogram ( EEG ) sleep stage data ( e.g. , rapid eye movement ; REM latency ) did not predict treatment responses .',\n",
      "  'These 1-week treatment results suggest that bright light might produce benefits for patients with nonseasonal depression .',\n",
      "  'Bright light should not be recommended for routine clinical application before additional assessment s with longer treatment duration s are done'],\n",
      " ['In this study , the effect of bright white light ( 2500 lux ) and dim light ( 50 lux ) were assessed in 30 patients with non-seasonal major depressive disorder r and omly assigned to either '\n",
      "  'procedure .',\n",
      "  'Patients met RDC for major depressive disorder and ICD-9 criteria ( 296.1 and 296.3 ) .',\n",
      "  'During a 7-day period , the patients were exposed to bright white light ( 2500 lux ) or dim light ( 50 lux ) from 7.00 to 9.00 h daily .',\n",
      "  'The severity of depression was assessed with observer scales ( AMDP system , Hamilton depression scale , CGI ) and through self-evaluation by self-rating scales ( depression scale and list of '\n",
      "  'complaints by von Zerssen ) .',\n",
      "  'No difference was noted between bright light therapy and dim light , though a significant reduction of depressive symptomatology was observed for all patients during the study .',\n",
      "  'These findings are discussed from a clinical point of view'],\n",
      " ['The assumption that depressed patients who are assigned to placebo in antidepressant clinical trials are exposed to substantial morbidity and mortality has not been based on research data .',\n",
      "  'Because of worldwide concern about placebo use and the implication s of our earlier findings of no increased suicide risk in  placebo-treated  patients , we conducted a replication study in a new '\n",
      "  'patient sample .',\n",
      "  'We assessed suicide risk and symptom reduction among  placebo-treated patients participating in antidepressant clinical trials for two recently approved antidepressants  , venlafaxine ER and '\n",
      "  'citalopram , which were unavailable during our previous study .',\n",
      "  'Among 23,201 participant patients , 32 committed suicide and 172 attempted suicide .',\n",
      "  'Rates of suicide and attempted suicide did not differ significantly among the placebo- and drug-treated groups .',\n",
      "  'Based on patient exposure years , annual rates of suicide and attempted suicide were 0.5 and 6.7 % with placebo , 0.9 % with active comparator ( rates for attempted suicide are unavailable ) , '\n",
      "  'and 0.6 and 6.3 % with investigational antidepressants .',\n",
      "  'Symptom reduction was 47.9 % with investigational drugs ( n = 1172 ) , 47.5 % with active comparators ( n = 161 ) , and 35.5 % with placebo ( n = 606 ) .',\n",
      "  'These data may inform discussion s about the use of placebo in antidepressant clinical trials'],\n",
      " [\"Prior analyses from the National Institute of Mental Health Treatment of Depression Collaborative Research Program indicated that patients ' expectancies of treatment effectiveness ( S. M. Sotsky \"\n",
      "  'et al. , 1991 ) and the quality of the therapeutic alliance ( J. L. Krupnick et al. , 1996 ) predicted clinical improvement .',\n",
      "  \"These data were reanalyzed to examine the hypothesis that the link between treatment expectancies and outcome would be mediated by patients ' contribution to the alliance .\",\n",
      "  'Among 151 patients who completed treatment , this hypothesis was supported , suggesting that patients who expect treatment to be effective tend to engage more constructively in session , which '\n",
      "  'helps bring about symptom reduction .',\n",
      "  \"Therapists ' expectancies for patient improvement also predicted outcome , although this association was not mediated by the alliance .\",\n",
      "  'None of the expectancy scales interacted with alliance ratings in the prediction of clinical improvement']]\n"
     ]
    }
   ],
   "source": [
    "with open('biobert_extractive_only_training_dataset/15106233.pkl', 'rb') as file:\n",
    "    investigate_pkl = pickle.load(file)\n",
    "\n",
    "pprint(investigate_pkl['sentences'], width=200)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 76,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "('METHODS We conducted a double-blind , r and omized clinical trial to investigate whether levosimendan reduces the severity of organ dysfunction in adults with sepsis . The primary outcome was the '\n",
      " 'mean daily Sequential Organ Failure Assessment ( SOFA ) score in the intensive care unit up to day 28 ( scores for each of five systems range from 0 to 4 , with higher scores indicating more '\n",
      " 'severe dysfunction ; maximum score , 20 ) . More patients in the levosimendan group than in the placebo group had supraventricular tachyarrhythmia ( 3.1 % vs. 0.4 % ; absolute difference , 2.7 '\n",
      " 'percentage points ; 95 % CI , 0.1 to 5.3 ; P=0.04 ) . CONCLUSIONS The addition of levosimendan to st and ard treatment in adults with sepsis was not associated with less severe organ dysfunction '\n",
      " 'or lower mortality . ( Funded by the NIHR Efficacy and Mechanism Evaluation Programme and others ; LeoPARDS Current Controlled Trials number , IS RCT N12776039 . ). Methods and Results — In this '\n",
      " 'prospect i ve , r and omized , blinded study , 23 patients received either levosimendan ( 0.1 and 0.2 & mgr;g · kg−1 · min−1 ; n=12 ) or placebo ( n=11 ) after aortic valve replacement for aortic '\n",
      " 'stenosis . The effects on LV performance , dimensions , filling patterns , and isovolumic relaxation time , as well as systemic hemodynamics , were assessed by pulmonary artery thermodilution '\n",
      " 'catheterization and transesophageal 2-dimensional Doppler echocardiography . There was a trend for an increase in LV ejection fraction ( 12 % ; P=0.058 ) with levosimendan . There were no '\n",
      " 'significant differences in systolic , diastolic arterial , or LV filling pressures or LV end-diastolic area between the 2 groups . Isovolumic relaxation time decreased ( −23 % ; P<0.001 ) , as did '\n",
      " 'the deceleration slope of early diastolic filling ( −45 % ; P<0.01 ) , whereas peak early diastolic filling velocity ( 16 % , P<0.01 ) and peak late diastolic filling velocity ( 15 % ; P<0.001 ) '\n",
      " 'increased after levosimendan compared with placebo . Microvascular and hemodynamic variables were analyzed using the Mann-Whitney rank sum test . The relative increase of perfused vessel density '\n",
      " 'vs. baseline was significantly higher in the levosimendan group than in the control group ( dMFIm 10 ( 3 ; 23)% vs. 0. ( -78 ; 57)% ; P < .001 ) . Conclusions Compared to a st and ard dose of 5 '\n",
      " 'μg·kg-1·min-1 of dobutamine , levosimendan at 0.2 μg·kg-1·min-1 improved sublingual microcirculatory blood flow in patients with septic shock , as reflected by changes in microcirculatory flow '\n",
      " 'indices of small and medium vessels . Trial registration NCT00800306. Background We aim ed to investigate the effect of levosimendan on biomarkers of myocardial injury and systemic hemodynamics in '\n",
      " 'patients with septic shock . Material / Methods After achieving normovolemia and a mean arterial pressure of at least 65 mmHg , 38 septic shock patients with low cardiac output ( left ventricular '\n",
      " 'ejective fraction ) , LEVF ≤45 % ) were r and omly divided into two groups : levosimendan dobutamine . During treatment we monitored hemodynamics and LVEF , and measured levels of heart-type fatty '\n",
      " 'acid binding protein ( HFABP ) , troponin I ( TNI ) , and brain natriuretic peptide(BNP ) . Results The levosimendan group and the dobutamine group were well matched with respect to age ( years , '\n",
      " '55.4±1 7.5 versus 50.2±13.6 ) and gender ( males , 68.4 % versus 57.9 % ) . There was no difference in the mechanical ventilation time , length of stay in ICU and hospital , and 28-day mortality '\n",
      " 'between the two groups . METHODS A prospect i ve single-center r and omized controlled trial was conducted . × kg⁻¹ ×. RESULTS Compared with dobutamine group , after the treatment in the '\n",
      " 'levosimendan  group , stroke volume index ( SVI ) , cardiac index ( CI ) and left ventricular stroke work index ( LVSWI ) were significantly increased [ SVI ( mL/m² ) : 39.8 ± 5.4 vs. 37.5 ± 4.5 , '\n",
      " 't=-2.762 , P=0.020 ; CI ( L × min⁻¹ × m⁻² ) :. 33.7 ± 2.4 vs. 28.2 ± 1.2 , t=-6.307 , P=0.000 ] , and central venous pressure ( CVP ) , intrathoracic blood volume index ( ITBVI ) and extravascular '\n",
      " 'lung water index ( EVLWI ) were significantly decreased [ CVP ( mmHg , 1 mmHg=0.133 kPa ) : 8.2 ± 0.9 vs. 12.1 ± 0.8 , t=3.928 , P=0.002 ; ITBVI ( mL/m² ) : 820 ± 42 vs. 978 ± 69 , t=9.472 , '\n",
      " 'P=0.000 ; EVLWI ( mL/kg ) : 6.1 ± 1.6 vs. 8.9 ± 1.7 , t=4.467 , P=0.001 ] . CONCLUSIONS Levosimendan can increase cardiac ejection function , reduce the heart blood and vascular preload , '\n",
      " 'intrathoracic lung water , improve heart function and systemic hemodynamic indexes of patients with septic shock. This r and omized , placebo-controlled trial showed that levosimendan '\n",
      " 'administration causes a significant reduction of circulating proinflammatory cytokine interleukin-6 and soluble apoptosis mediators , such as soluble Fas and Fas lig and in patients with '\n",
      " 'decompensated heart failure . These immunomodulatory effects may lead to improvement of symptoms and echocardiographic markers of cardiac contractile performance in these patients. Dynamic '\n",
      " 'positron emission tomography ( PET ) with [11C]acetate allows noninvasive assessment of myocardial oxygen consumption . In combination with echocardiography , PET enables determination of cardiac '\n",
      " 'efficiency ( defined as useful cardiac work per unit of oxygen consumption ) . We used this approach to compare the effects of levosimendan , a Ca2+‐dependent calcium sensitizer , with dobutamine '\n",
      " 'and sodium nitroprusside in healthy male volunteers . Dobutamine enhanced cardiac efficiency at the expense of increased oxygen requirement , but the effects of nitroprusside on kmono and cardiac '\n",
      " 'efficiency were neutral . This study shows the feasibility of PET in phase 1 pharmacodynamic studies and suggests potential energetical advantages of calcium sensitization with levosimendan. The '\n",
      " 'effects of inotropic agents on regional blood flow remains unknown . DESIGN Prospect i ve analysis . A dose of 0.3 mg/kg ICG was given through a cubital fossa vein as a bolus . RESULTS Statistical '\n",
      " 'analysis showed that the variation of hemodynamic variables was different between groups . There was a decrease in before- and after-infusion ICG-PDR values in dobutamine group ( 20.38 ± 4.83 vs '\n",
      " '20.34 ± 5.30 ) , and no statistical difference was detected ( P = .649 ) . Our objective was to determine the potential benefits of dobutamine on hemodynamic , metabolic , peripheral , '\n",
      " 'hepatosplanchnic and microcirculatory perfusion parameters during early septic shock resuscitation . Methods We design ed a r and omized , controlled , double-blind , crossover study comparing the '\n",
      " 'effects of 2.5-h infusion of dobutamine ( 5 mcg/kg/min fixed-dose ) or placebo in 20 septic shock patients with cardiac index ≥2.5 l/min/m2 and hyperlactatemia . Primary outcome was sublingual '\n",
      " 'perfused microvascular density . Results Despite an increasing cardiac index , heart rate and left ventricular ejection fraction , dobutamine had no effect on sublingual perfused vessel density [ '\n",
      " '9.0 ( 7.9–10.1 ) vs. 9.1 n/mm ( 7.9–9.9 ) ; p = 0.24 ] or microvascular flow index [ 2.1 ( 1.8–2.5 ) vs. 2.1 ( 1.9–2.5 ) ; p = 0.73 ] compared to placebo . ( 11.7–24.6 ) ; p = 0.03 ] and the '\n",
      " 'recovery slope of thenar muscle oxygen saturation after a vascular occlusion test [ 2.1 ( 1.1–3.1 ) vs. 2.5 % /s. DESIGN , SETTING , AND PARTICIPANTS. -13.0 % to 8.5 % ] ) . There was less use of '\n",
      " 'renal replacement therapy in the vasopressin group than in the norepinephrine group ( 25.4 % for vasopressin vs 35.3 % for norepinephrine ; difference , -9.9 %. TRIAL REGISTRATION clinical '\n",
      " 'trials.gov. IS RCT N 20769191.')\n"
     ]
    }
   ],
   "source": [
    "pprint(summaries_dataset[\"summary\"][0], width=200)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 81,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<Axes: >"
      ]
     },
     "execution_count": 81,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 600x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# view embeddings in reduced dimension, for the first abstract only\n",
    "from sklearn.decomposition import PCA\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "\n",
    "pca = PCA(n_components=2)\n",
    "\n",
    "#  filter by one abstract only\n",
    "abstract_id = 9\n",
    "\n",
    "# get relevant embeddings rows based on chosen abstract and its position in sentences\n",
    "start_sentence_id = sum([len(sentences) for sentences in summaries_dataset['sentences'][0][:abstract_id]])\n",
    "end_sentence_id = start_sentence_id + len(summaries_dataset['sentences'][0][abstract_id])\n",
    "\n",
    "relevant_embeddings = summaries_dataset['embeddings'][0][start_sentence_id:end_sentence_id]\n",
    "pca.fit(relevant_embeddings)\n",
    "embeddings_2d = pca.transform(relevant_embeddings)\n",
    "\n",
    "# was a sentence selected? check in `summary` (string)\n",
    "selected = []\n",
    "for i in range(len(summaries_dataset['sentences'][0][abstract_id])):\n",
    "    selected.append(summaries_dataset['sentences'][0][abstract_id][i] in summaries_dataset['summary'][0])\n",
    "\n",
    "# plot\n",
    "plt.figure(figsize=(6, 6))\n",
    "sns.scatterplot(x=embeddings_2d[:,0], y=embeddings_2d[:,1], style=selected)\n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.18"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
